Healthcare -
Biotechnology - NASDAQ - US
$ 0.47
-0.844 %
$ 27.3 M
Market Cap
-0.28
P/E
BCAB - COST OF REVENUE
Cost of Revenue BCAB - BioAtla, Inc.
104 M
LAST VALUE
783.14%
2 YEAR CAGR
31.58%
5 YEAR CAGR
0.00%
10 YEAR CAGR